Join
Live feed
·
INSIDERFilingvia Quantisnow
Zevra Therapeutics Inc. logo

President and CEO Mcfarlane Neil F. converted options into 233,334 shares and sold $853,425 worth of shares (91,000 units at $9.38), increasing direct ownership by 64% to 364,350 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ZVRA· Zevra Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZVRA (Zevra Therapeutics Inc.) and more on Quantisnow.